nContact Overview
- Year Founded
-
2005
- Status
-
Acquired/Merged
- Employees
-
47
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$117M
nContact General Information
Description
Developer of medical devices to perform minimally invasive ablation procedures. The company offers medical devices and technology to patients with enlarged atria, which is the vast majority of atrial flutter patients, who otherwise have no reliable treatment alternative.
Contact Information
Website
www.ncontact.usCorporate Office
- 1001 Aviation Parkway
- Suite 400
- Morrisville, NC 27560
- United States
Corporate Office
- 1001 Aviation Parkway
- Suite 400
- Morrisville, NC 27560
- United States
nContact Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Merger/Acquisition | 13-Oct-2015 | $117M | Completed | Generating Revenue | ||
| 8. Debt - General | 12-Nov-2014 | Completed | Generating Revenue | |||
| 7. Later Stage VC (Series D1) | 06-Mar-2013 | Completed | Generating Revenue | |||
| 6. Debt - General | 20-Jan-2012 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series D) | 11-Nov-2010 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series C1) | 09-May-2009 | Completed | Startup | |||
| 3. Later Stage VC (Series C) | 26-Nov-2007 | Completed | Startup | |||
| 2. Early Stage VC (Series B) | 03-Oct-2006 | $7.5M | $13M | Completed | Startup | |
| 1. Early Stage VC (Series A) | 01-Jul-2005 | $5.5M | $5.5M | Completed | Startup |
nContact Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series D1 | ||||||||
| Series D | ||||||||
| Series C1 | ||||||||
| Series C | ||||||||
| Series B | 2,619,080 | $0.000010 | 6% | $2.86 | $2.86 | 1x | $2.86 | 13.77% |
| Series A | 2,755,372 | $0.000010 | 6% | $2 | $2 | 1x | $2 | 14.49% |
nContact Patents
nContact Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2013116351-A | Diaphragm entry for posterior surgical access | Pending | 28-Feb-2013 | ||
| EP-2303154-A1 | Dissecting cannula and methods of use thereof | Inactive | 12-Jun-2008 | ||
| EP-2303154-A4 | Dissecting cannula and methods of use thereof | Inactive | 12-Jun-2008 | ||
| WO-2009152173-A1 | Dissecting cannula and methods of use thereof | Inactive | 12-Jun-2008 | ||
| EP-2274040-A1 | Articulating cannula access device | Inactive | 23-Apr-2008 | A61B1/00105 |
nContact Signals
nContact Former Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Bay Innovation Group | Accelerator/Incubator | Minority | ||
| Finistere Ventures | Venture Capital | Minority | ||
| Harbert Growth Partners | Growth/Expansion | Minority | ||
| Harbert Management | Asset Manager | Minority | ||
| Hippo Ventures | Venture Capital | Minority |
nContact FAQs
-
When was nContact founded?
nContact was founded in 2005.
-
Where is nContact headquartered?
nContact is headquartered in Morrisville, NC.
-
What is the size of nContact?
nContact has 47 total employees.
-
What industry is nContact in?
nContact’s primary industry is Surgical Devices.
-
Is nContact a private or public company?
nContact is a Private company.
-
What is the current valuation of nContact?
The current valuation of nContact is .
-
What is nContact’s current revenue?
The current revenue for nContact is .
-
How much funding has nContact raised over time?
nContact has raised $70.1M.
-
Who are nContact’s investors?
Bay Innovation Group, Finistere Ventures, Harbert Growth Partners, Harbert Management, and Hippo Ventures are 5 of 12 investors who have invested in nContact.
-
When was nContact acquired?
nContact was acquired on 13-Oct-2015.
-
Who acquired nContact?
nContact was acquired by Atricure.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process